xMAP® INTELLIFLEX Multiplexing Instrument
xMAP® INTELLIFLEX is the only compact, flow-based multiplex platform that combines the proven performance of xMAP Technology with modern features to enhance performance, empower assay development inn...
Luminex Corporation develops, manufactures, and sells proprietary technology, assays, and systems that empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. Our Molecular Diagnostics (MDx) and Life Science and Clinical Tools portfolios provide cost-effective, flexible solutions for hospitals, reference labs, and researchers, as well as innovative xMAP® and flow cytometry solutions that span a wide variety of applications, including molecular diagnostics, drug discovery, life science research, immunology, personalized medicine, cellular analysis, and more. Our goal is to transform global healthcare with innovative technology that delivers rapid, reliable results to clinicians and researchers. Most recently, we have been actively focused on providing diagnostic tests for SARS-CoV-2, with two diagnostic tests currently on the market. We are also pursuing several additional options in serology testing. For further information, please visit luminexcorp.com/.
xMAP® INTELLIFLEX is the only compact, flow-based multiplex platform that combines the proven performance of xMAP Technology with modern features to enhance performance, empower assay development inn...
The Luminex® 200™ detects up to 100 protein or nucleic acid analytes from a single aliquot of sample in a single reaction well, enabling you to generate more data while saving sample, time, and reagen...
The FLEXMAP 3D® detects up to 500 protein or nucleic acid analytes from a single aliquot of sample in a single reaction well, enabling you to generate more data while saving sample, time, and reagents...
xMAP® Technology uses color-coded microspheres to detect up to 500 protien or oligonucleotide analytes from a single aliquot of sample in a single reaction well, enabling you to generate more data whi...
xMAP® Technology uses color-coded microspheres to detect multiple analytes from a single aliquot of sample in a single reaction well, enabling you to generate more data while saving sample, time, and ...
Luminex Corporation develops, manufactures, and sells proprietary technology, assays, and systems that empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. Our Molecular Diagnostics (MDx) and Life Science and Clinical Tools portfolios provide cost-effective, flexible solutions for hospitals, reference labs, and researchers, as well as innovative xMAP® and flow cytometry solutions that span a wide variety of applications, including molecular diagnostics, drug discovery, life science research, immunology, personalized medicine, cellular analysis, and more. Our goal is to transform global healthcare with innovative technology that delivers rapid, reliable results to clinicians and researchers. Most recently, we have been actively focused on providing diagnostic tests for SARS-CoV-2, with two diagnostic tests currently on the market. We are also pursuing several additional options in serology testing. For further information, please visit luminexcorp.com/.